Cargando…

Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study

Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauritsen, Tine Bichel, Østgård, Lene Sofie Granfeldt, Grønbæk, Kirsten, Dalton, Susanne Oksbjerg, Nørgaard, Jan Maxwell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087397/
https://www.ncbi.nlm.nih.gov/pubmed/35997314
http://dx.doi.org/10.1002/hon.3068
_version_ 1785022337456799744
author Lauritsen, Tine Bichel
Østgård, Lene Sofie Granfeldt
Grønbæk, Kirsten
Dalton, Susanne Oksbjerg
Nørgaard, Jan Maxwell
author_facet Lauritsen, Tine Bichel
Østgård, Lene Sofie Granfeldt
Grønbæk, Kirsten
Dalton, Susanne Oksbjerg
Nørgaard, Jan Maxwell
author_sort Lauritsen, Tine Bichel
collection PubMed
description Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS.
format Online
Article
Text
id pubmed-10087397
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100873972023-04-12 Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study Lauritsen, Tine Bichel Østgård, Lene Sofie Granfeldt Grønbæk, Kirsten Dalton, Susanne Oksbjerg Nørgaard, Jan Maxwell Hematol Oncol Original Articles Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS. John Wiley and Sons Inc. 2022-09-06 2022-12 /pmc/articles/PMC10087397/ /pubmed/35997314 http://dx.doi.org/10.1002/hon.3068 Text en © 2022 The Authors. Hematological Oncology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Lauritsen, Tine Bichel
Østgård, Lene Sofie Granfeldt
Grønbæk, Kirsten
Dalton, Susanne Oksbjerg
Nørgaard, Jan Maxwell
Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title_full Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title_fullStr Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title_full_unstemmed Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title_short Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
title_sort socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: a population‐based cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087397/
https://www.ncbi.nlm.nih.gov/pubmed/35997314
http://dx.doi.org/10.1002/hon.3068
work_keys_str_mv AT lauritsentinebichel socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy
AT østgardlenesofiegranfeldt socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy
AT grønbækkirsten socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy
AT daltonsusanneoksbjerg socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy
AT nørgaardjanmaxwell socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy